Cargando…

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis

BACKGROUND: To accurately predict the prognosis of glioma patients. METHODS: A total of 541 samples from the TCGA cohort, 181 observations from the CGGA database and 91 samples from our cohort were included in our study. Long non-coding RNAs (LncRNAs) associated with glioma WHO grade were evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chunyu, Liu, Haitao, Xu, Pengfei, Tan, Yinqiu, Xu, Yang, Wang, Long, Liu, Baohui, Chen, Qianxue, Tian, Daofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941710/ https://www.ncbi.nlm.nih.gov/pubmed/33750353 http://dx.doi.org/10.1186/s12885-021-07972-9

Ejemplares similares

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients
por: Zhang, Chunyu, et al.
Publicado: (2022)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme
por: Yang, Ji’an, et al.
Publicado: (2020)

Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma
por: Li, Yong, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Glioma Stem Cell-Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
por: Ji, Baowei, et al.
Publicado: (2013)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
por: Xu, Yang, et al.
Publicado: (2019)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells
por: Guo, Zhentao, et al.
Publicado: (2014)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment
por: Li, Yong, et al.
Publicado: (2020)

5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma
por: Zhang, Chunyu, et al.
Publicado: (2022)

Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration
por: Shi, Zhenyi, et al.
Publicado: (2023)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
por: Weng, Nuo-Qing, et al.
Publicado: (2020)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Screening and Identification of an Immune-Associated lncRNA Prognostic Signature in Ovarian Carcinoma: Evidence from Bioinformatic Analysis
por: Li, Yan, et al.
Publicado: (2021)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

Prognostic potential of lncRNA RHPN1-AS1 in glioma
por: Wu, Yong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_poo1dl511u6qjih053jk4asmpn